ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0672

Does Obesity Affect Gout Risk Differently Among Genetically Predisposed Individuals?: Sex-Specific Prospective Cohort Study Findings over >32 Years

Chio Yokose1, Natalie McCormick2, Na Lu3, Amit Joshi2 and Hyon K. Choi4, 1Massachusetts General Hospital, Waltham, MA, 2Massachusetts General Hospital, Boston, MA, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Massachusetts General Hospital, Lexington, MA

Meeting: ACR Convergence 2021

Keywords: Adiposity, Epidemiology, genetics, gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I (0660–0682)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Two recent analyses of the Global Burden of Disease Study reported on the rising global burden of gout (Safiri A&R 2020, Xia Rheumatology 2020). Addressing obesity, a major modifiable risk factor for gout, may help alleviate this burden. However, it is also recognized that there is a significant genetic contribution to the risk of hyperuricemia and gout according to genome-wide association studies (GWAS) (Tin Nat Genet 2019). It is unknown whether obesity affects gout risk differently among genetically predisposed individuals. Our objective was to prospectively investigate the association between obesity and the risk of incident gout according to genetic predisposition in two large US cohorts over >32 years, stratified by sex.

Methods: We investigated the joint effects of obesity and genetic predisposition on the future risk of incident gout in 18,247 women in the Nurses’ Health Study (NHS) over 34 years and 10,899 men in the Health Professionals Follow-Up Study (HPFS) over 32 years. We derived a genetic risk score (GRS) using 114 serum urate single nucleotide polymorphisms from the latest GWAS (Tin), with higher GRS indicating higher genetic predisposition for hyperuricemia. We determined gene-body mass index (BMI) interactions among men and women separately. We also calculated the population attributable risk (PAR) for excess weight according to GRS stratum.

Results: We ascertained 1361 incident cases of self-reported gout in NHS and 1704 in HPFS. The baseline clinical gout risk factors were similar regardless of genetic predisposition within each cohort (Table 1). Among women, the multivariable relative risks (RR) of gout were 1.0, 1.24 (0.98 to 1.57), and 2.60 (2.09 to 3.24) among those with GRS below the mean and 1.55 (1.25 to 1.91), 2.74 (2.24 to 3.35), and 4.65 (3.80 to 5.68) among those with GRS above the mean for BMI categories < 25, 25-30, and >30, respectively (Figure 1 and Table 2). There was significant additive interaction with rate difference (RD) between BMI >30 relative to BMI ≤25 being 3.94 and 1.70/1000 person-years (PY) for GRS above and below the mean, respectively, resulting in relative excess risk due to interaction (RERI) of 1.48 (95% CI, 0.82 to 2.13) (p< 0.01). The results for men were similar in that the RR of excess weight appeared larger among men with GRS above the mean than below the mean (Figure 1 and Table 2); there was a similar trend, with a RD of 7.57 and 5.01/1000 PY for GRS above and below the mean, respectively, resulting in RERI of 0.58 (95% CI, -0.08 to 1.23) (p=0.08). Among women, excess weight accounted for a larger proportion of gout cases among those with GRS above the mean (PAR 48.5%, 95% CI, 38.8 to 55.9) compared to those with GRS below the mean (PAR 29.0%, 95% CI, 10.5 to 42.1). The PARs for men were similar within GRS strata (31.6% and 29.7%, respectively).

Conclusion: In these large prospective studies of men and women, we found a significant interaction between obesity and genetic predisposition among women, and a trend towards this in men. Maintaining healthy weight is an important gout prevention strategy, particularly among those with underlying genetic risk.


Disclosures: C. Yokose, None; N. McCormick, None; N. Lu, None; A. Joshi, None; H. Choi, None.

To cite this abstract in AMA style:

Yokose C, McCormick N, Lu N, Joshi A, Choi H. Does Obesity Affect Gout Risk Differently Among Genetically Predisposed Individuals?: Sex-Specific Prospective Cohort Study Findings over >32 Years [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/does-obesity-affect-gout-risk-differently-among-genetically-predisposed-individuals-sex-specific-prospective-cohort-study-findings-over-32-years/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-obesity-affect-gout-risk-differently-among-genetically-predisposed-individuals-sex-specific-prospective-cohort-study-findings-over-32-years/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology